Gossamer Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	55.54	48.47	114.7	-	-	-
Revenue Growth (YoY)	-55.42%	-57.74%	-	-	-	-
Gross Profit	55.54	48.47	114.7	-	-	-
Selling, General & Admin	47.72	37.63	36.13	38.46	47.61	45.78
Research & Development	179.13	181.57	138.49	145.3	170.98	170.34
Total Operating Expenses	226.85	219.2	174.62	183.76	218.59	216.12
Operating Income	-38.77	-170.73	-59.92	-183.76	-218.59	-216.12
Interest Income	2.03	1.97	1.78	2	1.58	0.76
Interest Expense	-11	-10.99	-11.52	-13.51	-13.88	-19.44
Other Non-Operating Income (Expense)	7.27	9.29	14.02	15.46	1.51	0.8
Total Non-Operating Income (Expense)	-1.7	0.27	4.28	3.94	-10.79	-17.88
Pretax Income	-38.27	-170.46	-55.64	-179.82	-229.38	-234
Provision for Income Taxes	-0.09	-0.09	0.89	-	-	-
Net Income	-38.27	-170.37	-56.53	-179.82	-229.38	-234
Net Income to Common	-38.27	-170.37	-56.53	-179.82	-229.38	-234
Shares Outstanding (Basic)	229	229	226	153	85	75
Shares Outstanding (Diluted)	229	229	226	153	85	75
Shares Change (YoY)	-0.25%	1.01%	48.23%	80.46%	13.00%	9.24%
EPS (Basic)	-0.79	-0.75	-0.25	-1.18	-2.71	-3.13
EPS (Diluted)	-0.79	-0.75	-0.25	-1.18	-2.71	-3.13
Free Cash Flow	-170.32	-171.35	-3.47	-159.16	-187.44	-190.44
Free Cash Flow Per Share	-0.74	-0.75	-0.02	-1.04	-2.22	-2.54
Gross Margin	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-69.80%	-352.23%	-52.24%	-	-	-
Profit Margin	-68.91%	-351.49%	-49.28%	-	-	-
FCF Margin	-306.67%	-353.50%	-3.02%	-	-	-
EBITDA	-37.87	-169.73	-55.77	-179.37	-214.16	-210.96
EBITDA Margin	-68.19%	-350.16%	-48.62%	-	-	-
EBIT	-38.77	-170.73	-59.92	-183.76	-218.59	-216.12
EBIT Margin	-69.80%	-352.23%	-52.24%	-	-	-
Effective Tax Rate	0.23%	0.05%	-1.61%	0.00%	0.00%	0.00%

SEC Filings: 10-K · 10-Q